These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3938814)

  • 21. Exponential tails of drug disposition curves: reality or appearance?
    Weiss M
    J Pharmacokinet Pharmacodyn; 2014 Feb; 41(1):49-54. PubMed ID: 24338373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug distribution in the body. I. Estimation of the kinetic rate and quantitation by statistical moments].
    LeBlanc PP; LeBel M
    J Pharm Belg; 1986; 41(2):69-74. PubMed ID: 3735052
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the physiological disposition and pharmacokinetics of 7-N-(p-hydroxyphenyl)-mitomycin C].
    Okumura S; Deguchi T; Nakamizo N
    Jpn J Antibiot; 1982 Aug; 35(8):1967-76. PubMed ID: 7154244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A linear recirculation model for drug disposition.
    Cutler DJ
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):101-16. PubMed ID: 458553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of drug disposition in the perfused rat brain by statistical moment analysis.
    Sakane T; Nakatsu M; Yamamoto A; Hashida M; Sezaki H; Yamashita S; Nadai T
    Pharm Res; 1991 Jun; 8(6):683-9. PubMed ID: 2062797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.
    Terasaki T; Sugiyama Y; Iga T; Sawada Y; Hanano M
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):265-87. PubMed ID: 4087165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of tissue distribution in determining drug disposition curves.
    Weiss M
    J Theor Biol; 1983 Aug; 103(4):649-52. PubMed ID: 6632929
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics: statistical moment calculations.
    Gouyette A
    Arzneimittelforschung; 1983; 33(1):173-6. PubMed ID: 6681972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.
    Veng-Pedersen P
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):627-48. PubMed ID: 6533297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model-independent assessment of accumulation kinetics based on moments of drug disposition curves.
    Weiss M
    Eur J Clin Pharmacol; 1984; 27(3):355-9. PubMed ID: 6510464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of prednisone and prednisolone in the perfused rabbit liver: modeling hepatic metabolic processes.
    Hale VG; Aizawa K; Sheiner LB; Benet LZ
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):597-614. PubMed ID: 1783993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical moments for placental transfer of solutes in man.
    Bernus I; Roberts MS; Rasiah RL; Mortimer RH
    J Pharm Pharmacol; 1999 Dec; 51(12):1381-9. PubMed ID: 10678492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics of mitomycin C and its derivative (KW-2083)].
    Fujita H
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1362-73. PubMed ID: 6820913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Jan; 99(1):475-85. PubMed ID: 19492340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictions of hepatic disposition properties using a mechanistically realistic, physiologically based model.
    Yan L; Sheihk-Bahaei S; Park S; Ropella GE; Hunt CA
    Drug Metab Dispos; 2008 Apr; 36(4):759-68. PubMed ID: 18227144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms.
    Collier PS
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):93-105. PubMed ID: 6875813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of mitomycin C in non-oat cell carcinoma of the lung.
    Buice RG; Niell HB; Sidhu P; Gurley BJ
    Cancer Chemother Pharmacol; 1984; 13(1):1-4. PubMed ID: 6428762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of drug absorption after oral administration.
    Chan KK; Gibaldi M
    J Pharm Sci; 1985 Apr; 74(4):388-93. PubMed ID: 3998998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.